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T cell motility as modulator of
interactions with dendritic cells
Jens V. Stein*
Theodor Kocher Institute, University of Bern, Bern, Switzerland
It is well established that the balance of costimulatory and inhibitory signals during
interactions with dendritic cells (DCs) determines T cell transition from a naïve to an
activated or tolerant/anergic status. Although many of these molecular interactions are
well reproduced in reductionist in vitro assays, the highly dynamic motility of naïve T cells
in lymphoid tissue acts as an additional lever to fine-tune their activation threshold. T
cell detachment from DCs providing suboptimal stimulation allows them to search for
DCs with higher levels of stimulatory signals, while storing a transient memory of short
encounters. In turn, adhesion of weakly reactive T cells to DCs presenting peptides
presented on major histocompatibility complex with low affinity is prevented by lipid
mediators. Finally, controlled recruitment of CD8+ T cells to cognate DC–CD4+ T cell
clusters shapes memory T cell formation and the quality of the immune response.
Dynamic physiological lymphocyte motility therefore constitutes a mechanism to mitigate
low avidity T cell activation and to improve the search for “optimal” DCs, while contributing
to peripheral tolerance induction in the absence of inflammation.
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T LYMPHOCYTES ARE CELLS THAT SCAN
THE SURFACES OF OTHER CELLS
A defining feature of T cells is their ability to become activated by pathogen-derived peptides
presented on major histocompatibility complexes (pMHCs), while remaining quiescent when self-
peptides are presented. Although in vitro experiments have successfully delineated the molecular
requirements for TCR triggering and continue to serve as important experimental tool to analyze
T cell activation, there is a factor that is difficult to reproduce in reductionist in vitro approaches:
isolated naive T cells are typically immotile in vitro without prior activation, whereas these cells
are remarkably motile in vivo. Direct observation of T cell behavior using intravital two photon
microscopy (2PM) has shown that these cells have a polarized, amoeboid-like shape, and move in
resting lymphoid tissue with speeds of ~12–15μm/min, in an apparently random manner (1–5).
Similarly, effector T cells in non-lymphoid tissues, including leptomeningeal membranes (6), liver
(7), and pancreas (8), show continuous motility, although the tissue microarchitecture is likely to
restrict T cell motility, in particular, in tightly packed epithelial layers of the skin (9). The dynamic
motility has evolved because T cells are MHC restricted and therefore need to physically scan the
surfaces of other cells. This process is balancedwith rapid decision-making onwhether to arrest (e.g.,
to exert cytotoxic activity against a target cell) or to continue migration. A central feature of T cell
biology is therefore their ability to transit from a highly motile to a stationary phenotype, i.e., from
vigorous scanning to firm adhesion. Decision-making of whether to “stop” or to “go” is probably
most critical in lymphoid tissue, such as peripheral lymph nodes (PLNs), where T cells move with
highest speeds and are therefore only in short contact with pMHC-presenting dendritic cells (DCs).
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In fact, it has been estimated that each DC is contacted by
~500–5000 T cells per hour, mostly for less than a few min (10,
11). This raises two questions: first, how is the T cell motility
induced in lymphoid tissue, and second, which factors influence
T cell decision-making for fast arrest?
REGULATION OF T CELL MOTILITY
IN LYMPHOID TISSUE
The PLN parenchyme consists of a sponge-like network of loosely
spaced fibroblastic reticular cells (FRCs) expressing the promi-
gratory chemokines CCL19 and CCL21, ligands for the CCR7
chemokine receptor present on naïve T cells (12). DCs are closely
attached to the FRC network to facilitate their continuous scan-
ning by T cells (13). Furthermore, the LFA-1 ligands ICAM-1 and
ICAM-2 are expressed on both DCs and FRCs, while CCL21 is
deposited onDCs (14, 15). 2PM imaging experiments have shown
that CCR7 ligands and LFA-1–ICAM-1 interactions contribute to
basalmigration, although even in their absence, T cells retain their
amoeboidmigrationmode and attain considerable average speeds
of ~10–12μm/min (16–19). In line with these observations, T
cells lacking the Gαi2 subunit acting downstream of CCR7 move
only slightly slower than WT T cells in PLN parenchyme (20).
Chemokines and integrins induce T cell polarization and the
formation of a leading edge and uropod as a result of multiple
signaling cascades revised elsewhere (21–24). In brief, continuous
Rac-mediated F-actin assembly at the leading edge, or lamel-
lipodium, provides the protrusion force in 3D environments,
even in the absence of integrin ligands (25). This is reflected
in T cells lacking the DOCK2 guanine exchange factor for the
small GTPase Rac1 and 2. These cells display strongly impaired
in vitro motility (26), and similar to Rac1/2-double-deficient T
cells, show virtually no residual migration in PLN parenchyme
(27, 28). Thus, LFA-1, CCR7, and other, as of yet unknown factors
lead to DOCK2–Rac-driven T cell motility. The importance of
this pathway for host surveillance is underscored by the recent
identification of DOCK2-deficient patients, who suffer from early
onset severe invasive infections (29).
Furthermore, lysophosphatidic acid (LPA) produced by the
exoenzyme autotaxin (ATX) on stromal cells, including high
endothelial venules (HEVs) and FRCs, contributes to transmigra-
tion and basal lymphocyte motility in PLNs (30–34). LPA binds
to T cell-expressed LPA2, a member of the GPCR family, and
induces Rho activation, which cooperates with CCL21 to induce
contractility-dependent lymphocyte migration. Pharmacological
blocking of ATX or LPA receptors or lack of LPA2 reduces T cell
speeds by ~30% in vivo, while addition of LPA increases T cell
polarization and speeds in vitro (30, 31, 33). These observations
are in line with recent descriptions of increased cell motility gen-
erated by augmented contractility of the trailing edge in confined
environments (35, 36). Similarly, T cells crossing endothelial bar-
riers is facilitated by theRho-GTP effector ROCKandMyosin IIA-
mediated contractility to move the nucleus through narrow pores
and for detachment of LFA-1–ICAM-1 adhesions (25, 37, 38).
Finally, in vitro and in vivo experiments support a role for tyrosine
kinase signaling downstream chemokine receptor signaling in T
cells. Thus, inhibition with Janus kinases (JAK) prevents T cell
chemotaxis to CCL21, adhesion to HEVs and homing (39–41). Of
note, interstitial motility within lymphoid tissue was not affected
by the absence of JAK1 and JAK2, pointing to compensatory
mechanisms that ensure robust motility.
DYNAMIC CONTROL OF T CELL ARREST
Ground-breaking work by Dustin and colleagues has uncovered
that in vitro generated chemotactic gradients, including the pro-
totypic T cell-attracting chemokine CCL21, are capable to disrupt
TCR–pMHC complexes, leading to detachment from antigen-
presenting cells and blunted T cell activation (42, 43). Although
CCL21 gradients have been confirmed in interfollicular regions
of PLNs (44), it remains unclear whether such gradients exist in
the paracortical T cell zone or around HEVs, where naive T cells
first encounter DCs (45). Interestingly, mice lacking promigra-
tory CCR7 ligands show a delayed but ultimately enhanced T
cell responses during immune responses (46). The delayed onset
may result from lack of efficient T cell–DC encounters at early
time points, while exceeding T cell responses at later time points
are consistent with an immunosuppressive action of CCL21 via
disruption of weakly reactive T cell – DC interactions.
Two photon microscopy analysis has helped to subdivide T
cell–DC interactions into distinct phases that are regulated by sur-
face levels of pMHC on DCs, as well as the TCR–pMHC affinity.
Thus, high levels of cognate pMHC are able to induce immediate
arrest of reactive T cells, whereas low levels result in a continuous
scanning behavior of T cells (47–49). During scanning, which can
last up to 8 h and is referred to as “phase 1,” T cells are able to
summate signals through activeNFAT and c-fos signaling (50, 51).
In addition to pMHC, ICAM-1 onDCs facilitates T cell arrest (52),
whereas regulatory T cells (Tregs) prevent stable interactions with
DCs in this phase (53, 54). “Phase 2” stable T cell–DC interactions
last for several hours and are commonly thought to be critical for
full T cell activation through the formation of an immunological
synapse (IS). Thus far, the precise duration of individual stable
T cell–DC contacts has proven difficult to assess in vivo, owing
to technical limitations maintaining physiological conditions and
the identical field of view during intravital imaging. After ~20 h
post T cell transfer, activated T cells resume motility and detach
from DCs before committing to cell division, in the so-called
phase 3 (Figure 1A).
Early in vitro evidence suggests that decision-making leading to
arrest on DCs may require only a few seconds and correlates with
induction of Ca flux in responsive T cells (56, 57). Interestingly,
dynamic DOCK2-driven F-actin assembly at the leading edge of
motile T cells ismaintained during interactionswithDCs, butwith
a different spatial arrangement at the IS interface. TCR signal-
ing and ICAM-1–LFA-1-mediated adhesion convert Rac-driven
protrusion activity at the lamellipodium of migrating T cells into
an annular F-actin ring with centripetal directionality at the IS
interface (58, 59). Combining these in vitro observations with
2PM data, the decision-making of motile T cells to undergo con-
version from translocation to arrest requires a threshold pMHC
level on DCs, sufficient integrated signals from previous DC
encounters and LFA-1-mediated firm adhesion. Weak activatory
signals because of low pMHC levels, low TCR–pMHC affinity or
Frontiers in Immunology | www.frontiersin.org November 2015 | Volume 6 | Article 5592
Stein Motility controls T cell activation
FIGURE 1 |Motile T cell–DC interactions in lymphoid tissue. (A) Phases
of interactions between pMHC-loaded DCs and T cells after their entry into
lymph nodes. Phase 1 is characterized by transient interactions, whereas T
cells engage stably with DCs during phase 2. In phase 3, T cells detach from
DCs and begin to divide before egressing as effector T cells. Adapted from
Ref. (55). (B) Regulation of weak T cell–DC interactions by TXA2 secretion.
TP-induced motility prevents stable T cell attachment (phase 1–2 transition)
unless a critical pMHC threshold is presented on DCs, thus ensuring a high
quality of ensuing CD4+ T cell responses. (C) Secretion of CCR5 ligands
CCL3 and CCL4 by pairs of interacting CD4+ T cells and DCs attract naïve
CD8+ T cells and helps to foster CD4+ T cell help. By contrast, excessive
CCR5 ligand production in the absence of Tregs deteriorates the quality of
CD8+ T cell responses by allowing weakly interacting clones to attach to DCs.
lack of ICAM-1 on DCs would be insufficient to trigger F-actin
conversion to a ring-like structure. Consistent with this model,
inhibitory receptors of TCR signaling including CTLA-4 and PD-
1 prevent T cell adhesion to antigen-presenting cells (60–62).
Recent work by Krummel and colleagues has shown that naïve
T cells express Myo1g, a regulator of membrane tension. When
T cells are exposed to physical pressure, Myo1g accumulates at
the spot of pressure exertion, followed by adjacent generation of a
newly formed F-actin protrusion (63). In vitro and in vivo assays
uncovered that Myo1g activity results in a meandering migra-
tion pattern, since Myo1g-deficient T cells showed less turning
behavior and higher directionality. As a result, Myo1g-deficient
T cells displayed shorter interaction times with DCs in vivo, as the
average scanning time decreased from~1.7 to 1min. This reduced
interaction time had a significant impact for T cell engagement
with rare DCs, sinceMyo1g-deficient T cells were unable to “read”
enough DC activation signals for arrest conversion and main-
tained their migratory behavior (63). In sum, in vivo migrating
T cells need a minimal DC scanning time of ~100 s to integrate
sufficient TCR signals for a successful conversion of protruding
to annular F-actin and IS formation. This process is supported by
LFA-1 adhesion to ICAM-1 on DCs.
THROMBOXANE A2-INDUCED MOTILITY
AS QUALITY CONTROL FOR CD4+ T CELL
RESPONSES
Activated DCs increase surface expression of costimulatory
molecules and are therefore able to efficiently activate T cells,
including weakly reactive or potentially self-reactive clones.
Work by Sanui and colleagues has identified activated DCs and
macrophages as important source of thromboxane A2 (TXA2).
TXA2 is a secreted lipid with short half-life that binds the
Gα12/13-coupled TP receptor expressed on naïve but not effec-
tor/memory T cells. Binding of TXA2 to TP induces lsc (also
known as p115 RhoGEF or ArhGEF1)-mediated Rho activation
(64), which induces chemokinetic motility in vitro and disruption
of T cell–DC pairs (65). In a recent study, TXA2 was shown
to specifically thwart the activation of weakly reactive CD4+ T
cell clones. After immunization or infection, Ag-specific CD4+
T cells that bound tetramers only weakly expanded significantly
more in the absence of TP. Using 2PM imaging of reactive PLNs,
the absence of TP on naïve CD4+ T cells resulted in increased
interactions with DCs presenting low amounts or weak agonist
pMHC, leading to a premature phase 1 to phase 2 transition and
excessive T cell expansion (Figure 1B). By contrast, WT- and TP-
deficient CD4+ T cells similarly engaged with DCs presenting
high amounts of agonist pMHC, indicating that TXA2 preferen-
tially prevents arrest of weakly reactive T cell clones (66). Thus,
TXA2 allows T cells to maintain their search for DCs present-
ing high levels of cognate pMHC, rather than weak agonist or
self-peptides. Indeed, TXA2-mediated quality control of early T
cell–DC interactions prevented the excessive generation of follic-
ular helper cells, which provide help to weakly reactive germinal
center B cells. As consequence, lack of TXA2–TP signaling during
T cell priming deteriorated the overall quality of the ensuing
immune response (66).
TIGHTLY REGULATED CCR5 LIGAND
EXPRESSION CONTROLS THE QUALITY
OF CD8+ T CELL RESPONSES
A comparable link between the quality of adaptive immune
responses and low affinity-driven interactions was made when
examining how the absence of Tregs affected CD8+ T cell
engagement with DCs. Previous work had shown that baseline
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production of CCR5 ligands CCL3 and CCL4 leads to the recruit-
ment of naive CD8+ T cells to DC engaged in productive inter-
actions with CD4+ T cells, resulting in CD4+ T cell help and
effective CD8+ T cell memory formation (67). By contrast,
in the absence of Tregs, DCs produced increased amounts of
CCR5 ligands that facilitated excessive engagement of CD8+
T cells with DCs presenting low-affinity pMHC complexes as
assessed by 2PM imaging (Figure 1C). This resulted in an overall
lower quality of the adaptive immune responses, since the ratio
of low versus high avidity clones was shifted towards the for-
mer population (68). Thus, similar to TXA2, motility-inducing
agents influence T cell–DC interactions inside reactive PLNs
that contain highly stimulatory DCs. It is interesting to note
that in non-reactive PLNs, the absence of CCR5 ligand produc-
tion and TXA2 permits unbiased scanning of resident DCs by
naïve T cells, which is essential for efficient peripheral tolerance
education.
CONCLUDING REMARKS
Two photon microscopy-based investigation of T cell–DC inter-
actions has uncovered factors that, in addition to pMHC abun-
dance and affinity, regulate the dynamic interplay between these
two cell types. Although tightly regulated T cell attraction to
activated DCs promote adaptive immune responses by allowing
rare cells to meet, excessive interactions with low-affinity pMHC-
presentingDCs deteriorate the overall quality of clonal expansion.
Furthermore, intrinsic wiring of the migratory behavior of T cells
facilitates their scanning function. Thus, programmed Myo1g-
induced meandering behavior permits sufficiently long interac-
tions between T cells and DCs. In addition, continuous F-actin
treadmilling during both migration and IS formation endows
T cells with the capacity to quickly switch between migratory
versus stationary modes. Thus, upon cessation of TCR signaling,
T cells resume their motility, presumably to avoid overstimu-
lation and to prepare for egress. These observations raise new
interesting questions. For example, is the duration of phase 2-like
stable interactions regulated by external chemoattractant gradi-
ents or cell-intrinsic mechanisms? Furthermore, desensitization
of chemokine receptors, such as CCR5, and its impact on T cell
motility patterns in vivo has not been investigated in detail. Such
studies are relevant since CCR5 ligands attract cognate and non-
cognate naïve CD8+ T cells, andwould rapidly limit access toDCs
unless CCR5 desensitization is allowing cell turnover. The con-
tinued examination of mechanisms that control T cell motility in
lymphoid tissue and their impact on adaptive immune responses
will remain a productive field of research in years to come.
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